News Release
<< Back
Ra Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 25, 2018-- Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that Doug Treco, PhD, President and Chief Executive Officer of Ra Pharma, will present at the 2018 Cantor Global Healthcare Conference on Tuesday, October 2, 2018 at 9:10 a.m. E.T. The conference is being held at the InterContinental New York Barclay Hotel.

The presentation will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

Source: Ra Pharmaceuticals, Inc.

Investors:
Argot Partners
Natalie Wildenradt, 212-600-1902
natalie@argotpartners.com
or
Media:
Argot Partners
David Rosen, 212-600-1902
david.rosen@argotpartners.com